Primary relevance to vitamin D Vitamin D is a stated subject of this paper.
Vitamin D is a stated subject of this paper; the supporting source evidence is shown below.
Why this paper is included
Supporting source evidence:
The retrospective data analysis on 80 patients from 2018 to 2022 aimed to determine the incidence and clinical outcomes of vitamin D status and myeloma bone disease among newly diagnosed multiple myeloma (MM) patients in Singapore.
Source: Abstract. View original paper
Relevance classification does not establish study quality, causation or editorial approval.
Study design Cohort study.
Cohort study
Examines exposures and outcomes over time within a defined group.
Meta-analysis unclear · Blinding unclear / not reported · Human research reported
How this paper was classified
Automatic source-based classification; awaiting editorial verification. This is not a quality score.
Incidence and Clinical Outcomes of Vitamin D Status and Myeloma Bone Disease Among Patients With Newly Diagnosed Multiple Myeloma (MM) in a Tropical Country: Retrospective Cohort Study
Source: Article title.
Some of the patients were referred to a myeloma advanced practice nurse for supportive care management post‐transplant, in which bone health is one of the core supportive care interventions after completion of the transplant.
Source: Methods.
What the study types mean
- Systematic review
- Uses explicit methods to identify, assess and summarise research on a defined question.
- Scoping review
- Maps the extent and characteristics of research on a topic.
- Narrative review
- Discusses existing research; systematic-review methods have not been established by this classification.
- Review / evidence synthesis
- Reviews existing research; the exact review methods need further assessment.
- Randomised controlled trial
- Assigns participants or groups to comparison interventions by chance.
- Non-randomised intervention study
- Examines an intervention without random allocation.
- Cohort study
- Examines exposures and outcomes over time within a defined group.
- Case-control study
- Compares people with an outcome against people without it, examining exposures.
- Cross-sectional study
- Examines a population at a particular point in time.
- Observational study
- Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
- Case report
- Describes an individual case.
- Case series
- Describes a group of individual cases.
- Secondary analysis
- Analyses existing study data; this paper is not automatically another independent trial.
- Laboratory study
- Investigates biological processes in a laboratory setting.
- Qualitative study
- Examines experiences or meanings using qualitative methods.
- Genetic instrumental-variable study
- Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
- Study protocol
- Describes planned methods and is not evidence that the planned study has reported results.
- Multiple reported designs
- More than one design is explicitly reported; examine the supporting methods.
- Study design awaiting verification
- The available source does not establish a sufficiently clear study design.
Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.
Abstracts
Incidence and Clinical Outcomes of Vitamin D Status and Myeloma Bone Disease Among Patients With Newly Diagnosed Multiple Myeloma (MM) in a Tropical Country: Retrospective Cohort Study
Cohort study · Cancer Reports · 2025
Original publication title
Incidence and Clinical Outcomes of Vitamin D Status and Myeloma Bone Disease Among Patients With Newly Diagnosed Multiple Myeloma (MM) in a Tropical Country: Retrospective Cohort Study
© 2025 The Author(s). Cancer Reports published by Wiley Periodicals LLC.
Original publication · Publisher record · CC BY 4.0
Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.
At a glance
Abstract: What objectives does the paper state?
The retrospective data analysis on 80 patients from 2018 to 2022 aimed to determine the incidence and clinical outcomes of vitamin D status and myeloma bone disease among newly diagnosed multiple myeloma (MM) patients in Singapore.
Source: ObjectiveAbstract: What methods does the paper describe?
Patients' demographics, bone health data and bone disease management were collected. Chi‐square test was conducted to compare variables between patients who survived versus those who demised. Survival differences were compared using log‐rank analysis and plotted using Kaplan: Meier estimates. Multivariable survival analysis was conducted using Cox Regression.
Source: MethodAbstract: Results
Fifty‐nine (73.8%) patients had myeloma bone disease at diagnosis, and 42 (71.2%) of these patients had skeletal‐related adverse events at diagnosis. The compliance to bone health management needs to be optimized, as only 70 patients had their vitamin D level tested at diagnosis, of which 48 (68.7%) patients were vitamin D insufficient or deficient. Bone disease data did not correlate with mortality. Higher mortality was initially observed among patients with non‐Chinese (p = 0.03), R‐ISS 3 (p = 0.001), and renal involvement at diagnosis (p = 0.035).
R‐ISS staging remained the only statistically significant variable after adjusting for race (adjusted HR 3.99; 95% CI 1.58 to 10.07).
Source: ResultsAbstract: Conclusion
The study found no correlation between myeloma bone health data and survival outcomes in our centre.
Source: ConclusionAuthors’ abstract
ABSTRACT
Objective
The retrospective data analysis on 80 patients from 2018 to 2022 aimed to determine the incidence and clinical outcomes of vitamin D status and myeloma bone disease among newly diagnosed multiple myeloma (MM) patients in Singapore.
Method
Patients' demographics, bone health data and bone disease management were collected. Chi‐square test was conducted to compare variables between patients who survived versus those who demised. Survival differences were compared using log‐rank analysis and plotted using Kaplan: Meier estimates. Multivariable survival analysis was conducted using Cox Regression.
Results
Fifty‐nine (73.8%) patients had myeloma bone disease at diagnosis, and 42 (71.2%) of these patients had skeletal‐related adverse events at diagnosis. The compliance to bone health management needs to be optimized, as only 70 patients had their vitamin D level tested at diagnosis, of which 48 (68.7%) patients were vitamin D insufficient or deficient. Bone disease data did not correlate with mortality. Higher mortality was initially observed among patients with non‐Chinese (p = 0.03), R‐ISS 3 (p = 0.001), and renal involvement at diagnosis (p = 0.035).
R‐ISS staging remained the only statistically significant variable after adjusting for race (adjusted HR 3.99; 95% CI 1.58 to 10.07).
Conclusion
The study found no correlation between myeloma bone health data and survival outcomes in our centre.
Publication and source details
Original title: Incidence and Clinical Outcomes of Vitamin D Status and Myeloma Bone Disease Among Patients With Newly Diagnosed Multiple Myeloma (MM) in a Tropical Country: Retrospective Cohort Study
Chi Ching Lim; Wai San Wilson Tam; Widanalage Sanjay Prasad De Mel; Siew Ping Lang; Wee Joo Chng; Cinnie Yentia Soekojo; Fang Fang Song; Melissa Gaik Ming Ooi
Cancer Reports · 2025
* Correspondence:Chi Ching Lim (joanlimchiching@gmail.com)
© 2025 The Author(s). Cancer Reports published by Wiley Periodicals LLC.https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. Yong Siew Yoon Research Fellowship
Repository JATS snapshot; version as supplied
Source retrieved: 2026-11-11T00:41:51.304422+00:00
DOI: 10.1002/cnr2.70431 · PMC12723718